- Report
- February 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- July 2020
- 158 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- July 2022
- 100 Pages
Global
From €2639EUR$2,750USD£2,282GBP
From €4558EUR$4,750USD£3,941GBP
- Report
- March 2021
Global
From €8631EUR$8,995USD£7,463GBP
- Report
- May 2021
- 101 Pages
Global
From €4270EUR$4,450USD£3,692GBP
- Report
- January 2018
- 91 Pages
Global
From €3934EUR$4,100USD£3,402GBP
- Report
- July 2023
- 113 Pages
Global
From €3500EUR$3,908USD£3,132GBP
The Incentive Spirometer market is a subset of the larger Respiratory Devices market. Incentive Spirometers are medical devices used to measure the amount of air inhaled and exhaled by a patient. They are used to help patients with breathing problems, such as COPD, asthma, and cystic fibrosis, to improve their lung capacity. Incentive Spirometers are also used to help patients recover from surgery or other medical procedures. The devices are typically handheld and feature a mouthpiece, a tube, and a display. The patient inhales and exhales through the mouthpiece, and the device measures the amount of air inhaled and exhaled.
Incentive Spirometers are used in both hospital and home settings. They are typically used in conjunction with other respiratory devices, such as nebulizers and oxygen concentrators. The Incentive Spirometer market is highly competitive, with many companies offering a variety of devices. Some of the major players in the market include Philips Respironics, ResMed, Fisher & Paykel, and Vyaire Medical. Show Less Read more